Key result
Baseline diabetes significantly increased the odds of developing chronic kidney disease over 7 years (OR 3.11), alongside older age, male gender, and hypertension.
Why the study?
Data on the prevalence and associated factors of CKD in urban adults in Sri Lanka are limited despite rising global CKD rates linked to diabetes and hypertension.
Cohort (n=2,032)
No
Odds Ratio: 3.11 (95% CI 1.81–5.28)
p-value: p=<0.001
In an urban Sri Lankan cohort, the age-adjusted prevalence of CKD was 3.03%, driven primarily by diabetes and hypertension, highlighting the need for early detection and management.
Abstract Background Chronic kidney disease (CKD) affects approximately 850 million adults worldwide, with its prevalence rising due to increasing rates of diabetes and hypertension in ageing populations. This study aims to assess the prevalence and associated factors of CKD in an urban adult cohort in Sri Lanka, where such data is limited. Methods We conducted a stratified random sampling of participants from Ragama, Sri Lanka, initially in 2007(ages 35-64) and reassessed them in 2014. Data collection involved structured interviews, anthropometric measurements and biochemical tests. CKD was evaluated in 2014 using the estimated glomerular filtration rate (eGFR) calculated via the CKD-EPI formula, defining CKD as eGFR<60 ml/min/1.72 m² according to KDIGO/KDOQI guidelines. A follow-up in 2017 assessed all-cause and cardiovascular mortality and morbidity. Results Of 2,985 individuals recruited in 2007, 2148(71.6%) participated in the 2014 follow-up; 2,032(94.6%) had complete data to assess CKD status in 2014. Mean age of the participants was 52.3(SD 7.7) years; 57% were women. Age-adjusted prevalence of CKD was 3.03(1.98–4.11) per 100 population in 2014; most were Stage 3A(67.2%), followed by Stage 3B(23%) and Stage 4(9.8%). Older age (p<0.001), male gender (p<0.05), diabetes (p<0.001), and hypertension (p<0.001) at baseline were associated with CKD in 2014. No association was observed between CKD and all-cause or cardiovascular mortality or morbidity by 2017 (p>0.05). Conclusions Diabetes and hypertension are significant contributors to CKD prevalence, with most patients at Stage 3, where early detection and management can slow disease progression. CKD remains under-recognized in Sri Lanka, highlighting the need for extensive population-based studies to better understand this growing health issue better.
No takes yet. Share an insight, caveat, or question.
Silva et al. (2026) conducted a cohort in Chronic Kidney Disease (n=2,032). Baseline diabetes vs. Without baseline diabetes was evaluated on Presence of Chronic Kidney Disease (CKD) at 7-year follow-up (OR 3.11, 95% CI 1.81-5.28, p=<0.001). Baseline diabetes significantly increased the odds of developing chronic kidney disease over 7 years (OR 3.11), alongside older age, male gender, and hypertension.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: